Matthew Hobson
InvestorAnalyst at Catalio Capital Management, LP
Baltimore, Maryland
Writes $100K – $5M checks · typically $1.5M
Find your path to Matthew
Sign up to see every warm intro you have to Matthew
- Paths you didn't know you had: your email and LinkedIn already hold routes to Matthew. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Matthew Hobson is a Principal at Catalio Capital Management, where he focuses on therapeutics and diagnostics investments across the firm's venture and private credit strategies. He joined Catalio at its 2020 founding, having previously been a Postdoctoral Fellow at the Johns Hopkins School of Medicine, where he also earned a PhD in biophysics and biophysical chemistry. He holds a B.S. in chemistry and physics from Emory University.
Contact· self-published, not guessed
Invests in
BiotechDigital Health
Investments
Board seats
Iambic TherapeuticsLassen TherapeuticsOctant TherapeuticsPink Dx
Per the firm's website.
Colleagues at Catalio Capital Management, LP
Frequently asked questions
- Who is Matthew Hobson?
- Matthew Hobson is a Principal at Catalio Capital Management, where he focuses on therapeutics and diagnostics investments across the firm's venture and private credit strategies. He joined Catalio at its 2020 founding, having previously been a Postdoctoral Fellow at the Johns Hopkins School of Medicine, where he also earned a PhD in biophysics and biophysical chemistry. He holds a B.S. in chemistry and physics from Emory University.
- Where does Matthew Hobson work?
- Matthew Hobson is Analyst at Catalio Capital Management, LP.
- What does Matthew Hobson invest in?
- Matthew Hobson invests in Biotech, Digital Health.
- What check size does Matthew Hobson write?
- Matthew Hobson typically writes checks of $100K – $5M.
- What boards does Matthew Hobson sit on?
- Matthew Hobson holds tracked board seats at Iambic Therapeutics, Lassen Therapeutics, Octant Therapeutics, Pink Dx.
About this profile. Compiled from public sources — Catalio Capital Management, LP's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights








